Home » Topics » Inflammatory, BioWorld Science

Inflammatory, BioWorld Science
RSS

Pliant Therapeutics patents integrin alphavbeta6 antagonists

Jan. 21, 2020

Engineered enzyme alleviates intracellular NADH:NAD+ imbalance by targeting circulating lactate

Jan. 21, 2020

Conatus Pharmaceuticals discovers caspase inhibitors

Jan. 15, 2020

PPARgamma controls antifibrotic network

Jan. 3, 2020

Idorsia Pharmaceuticals patents lysophosphatidic acid receptor 1 antagonists

Dec. 27, 2019

New preclinical model of fibrosis

Dec. 20, 2019

Corbus Pharmaceuticals describes new cannabinoid CB2 receptor agonists

Dec. 19, 2019

Study shows causal link between elevated activity of type 1 interferon and human disease

Dec. 17, 2019

Acetyl CoA and metabolic health

Dec. 12, 2019

LAIMU synthesizes new compounds for allergy

Dec. 10, 2019

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Dec. 29, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Dec. 29, 2025.
Researchers discover how glioblastoma tumors dodge chemotherapy
BioWorld MedTech
Researchers at the University of Sydney have uncovered a mechanism that may explain why glioblastoma returns after treatment, and the world-first discovery offers...
Shionogi nabs revenue-generating ALS drugs with $2.5B Tanabe pact
BioWorld
Shionogi & Co. Ltd. will acquire global rights to U.S. FDA approved amyotrophic lateral sclerosis therapy edaravone through a $2.5 billion acquisition deal with...
Big pharma taps fast Asia innovation in search of next Keytruda
BioWorld
Speed and innovation from Asia Pacific’s (APAC) biotechnology sector had big pharma scouring the region for the next oncology heir to Keytruda (pembrolizumab),...